金威醫療(08143.HK):間接全資附屬公司Sino Business認購1250萬港元Edinburgh International股份 持股比例增至75%
格隆匯 10 月 5日丨金威醫療(08143.HK)公佈,2020年10月5日(交易時段後),公司間接全資附屬公司Sino Business簽署以公司的間接非全資附屬公司Edinburgh International為受益人的認購函件,據此,Sino Business以認購價每股認購股份人民幣114218.75元(約130209.38港元)認購96股認購股份(佔Edinburgh International經配發及發行認購股份擴大後的已發行股本的24%)。應付認購事項總代價為人民幣1096.5萬元(相當於約1250.0100萬港元)。完成後,Sino Business於Edinburgh International的股權由51%增加至75%。Edinburgh International將繼續為公司的間接非全資附屬公司。完成後,Edinburgh International的財務業績將繼續併入集團的綜合財務報表。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.